Spyre Therapeutics, Inc.

Report date
3/31/2022
Quarter
2022 Q1
Filed
5/12/2022
Shares
48,918
Value ($000)
113
Weight
0.0%
2019 Q4 - 2022 Q1 (10 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).